Table 1 The comparison of variables between ITP and control.

From: A design for an efficient functional panel that determines platelet exhaustion levels to differentiate responder and non-responder ITP patients

Variable

ITP

Control

P-value

Gender, n (%)

  

0.629

Male

11 (39.3%)

9 (45%)

 

Female

17 (60.7%)

11 (55%)

Age (y), Mean ± SD

20.68 ± 10.67

25.20 ± 10.20

0.108

Platelet indices, Mean ± SD

   

PLT count (*103/ml)

73.61 ± 59.42

196 ± 36

< 0.001

MPV13

11.48 ± 1.17

9.3 ± 0.96

< 0.001

PDW13

14.77 ± 2.21

11 ± 1.5

< 0.001

PLCR (%)

35.08 ± 7.33

21 ± 6.5

< 0.001

Clinical findings of patients, n (%)

Bleeding Score (BS)

BS 1

10 (35.7%)

BS 2

18 (64.3%)

Prior treatment

Treatment-naïve

8 (28.6%)

TPORA

14 (50%)

Corticosteroids

6 (21.4%)

Splenectomy

1 (4%)

Ongoing treatment at the time of sampling:

Corticosteroids (prednisone/dexamethasone)

8 (28.6%)

TPORA

12 (42.8%)

No active treatment (watch and wait)

8 (28.6%)

  1. BS, bleeding Score; MPV, mean platelet volume; PDW, platelet distribution width; P-LCR, platelet larger cell ratio; PLT, platelet; TPO-RA, thrombopoietin receptor agonists.
Back to article page